
Teleflex reports Q2 revenue growth and $2B divestitures, plans debt cut and share buybacks
Teleflex reported Q2 revenue of $570.3 million, driven by its Vascular and Surgical segments, with adjusted EPS up 1.7% to $1.76. The company is selling its Acute Care, Interventional Urology, and OEM businesses for about $2.03 billion in cash to red...

